Brief: LumiraDx Reports First Quarter 2023 Results
May 16 (Reuters) - Lumiradx Ltd LMDX.O :
* LUMIRADX REPORTS FIRST QUARTER 2023 RESULTS
* QTRLY LOSS PER SHARE $0.14
* LUMIRADX LD - ADDITIONAL RESTRUCTURING ACTIVITIES TO
REDUCE
GLOBAL WORKFORCE BY 40%
* EXPENSE REDUCTIONS RELATED TO RESTRUCTING ACTIVITIES
EXPECTED TO
BE OF $36 MILLION PER ANNUM WITH FULL IMPACT FROM JUNE 2023
ONWARD
* Q1 EARNINGS PER SHARE VIEW $-0.15 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9pLq8d
Further company coverage: LMDX.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing